This Article Full Text Full Text (PDF) All Versions of this Article: 36/8/1705    most recent 01.STR.0000173161.05453.90.9fv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ribo, M. Articles by Alvarez-Sabín, J. Search for Related Content PubMed PubMed Citation Articles by Ribo, M. Articles by Alvarez-Sabín, J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Stroke Related Collections Thrombolysis Acute Cerebral Infarction Emergency treatment of Stroke Doppler ultrasound, Transcranial Doppler etc. Fibrinolysis

(Stroke. 2005;36:1705.)
© 2005 American Heart Association, Inc.

Original Contributions

Acute Hyperglycemia State Is Associated With Lower tPA-Induced Recanalization Rates in Stroke Patients

Marc Ribo, MD, PhD; Carlos Molina, MD, PhD; Joan Montaner, MD, PhD; Marta Rubiera, MD; Raquel Delgado-Mederos, MD; Juan F. Arenillas, MD, PhD; Manuel Quintana José Alvarez-Sabín, MD, PhD

From the Unitat Neurovascular Hospital, Vall d'Hebron, Barcelona. Spain.

Correspondence to Marc Ribo, MD, PhD, Unitat Neurovascular Hospital, Vall d'Hebron, Passeig Vall d'Hebron 119–129, Barcelona 08035, Spain. E-mail marcriboj{at}hotmail.com

Background and Purpose— Hyperglycemia (HG) has a deleterious effect in stroke patients by accelerating ischemic brain damage; moreover, its antifibrinolytic effect may also influence reperfusion. We aimed to study the effect of acute/chronic HG on tissue-type plasminogen activator (tPA)–induced recanalization.

Methods— We studied 139 consecutive stroke patients with documented intracranial artery occlusion treated with intravenous tissue-type plasminogen activator (tPA). Admission glucose levels were recorded (in mg/dL). The existence of previous chronic HG was determined by plasma levels of glycosylated hemoglobin (HbA1c, %) and fructosamine (in µmol/L). Transcranial Doppler monitoring assessed complete recanalization 2 hours after tPA bolus. National Institutes of Health Stroke Scale (NIHSS) scores were obtained at baseline and 48 hours.

Results— On admission, the median NIHSS score was 18 and mean glucose value was140±63 mg/dL. At 2 hours, 32% of patients(n=44) achieved complete recanalization. Patients who recanalized showed lower admission glucose levels (127 vs 146 mg/dL; P=0.039) but no differences in HbA1c (6.3% vs 6.3%; P=0.896) or fructosamine (292 vs 293 µmol/L; P=0.957) were observed. Other variables associated with recanalization were initial distal middle cerebral artery occlusion (P=0.011) and platelet count (P=0.015). Patients with an admission glucose level >158 mg/dL had lower recanalization rates (16% vs 36.1%; P=0.035) and a higher NIHSS score at 48 hours (7 vs 14.5; P=0.04). After adjustment for stroke etiology, age, and risk factors, the only independent predictors on admission of no recanalization were glucose value >158 mg/dL (odds ratio [OR], 7.3; 95% confidence interval [CI], 1.3 to 42.3; P=0.027), proximal middle cerebral artery occlusion (OR, 2.6; 95% CI, 1.1 to 6.5; P=0.034), and platelet count <219 000/mL (OR, 2.6; 95% CI, 1.1 to 6.1; P=0.029).

Conclusions— In tPA-treated patients, the acute but not chronic HG state may hamper the fibrinolytic process, delaying reperfusion of the ischemic penumbra. Early measures to reduce HG may favor early recanalization.

Key Words: hyperglycemia • stroke, acute • thrombolysis • ultrasonography, Doppler, transcranial

This article has been cited by other articles:

				J. F. Arenillas, L. Ispierto, M. Millan, D. Escudero, N. Perez de la Ossa, L. Dorado, C. Guerrero, J. Serena, J. Castillo, and A. Davalos Metabolic syndrome and resistance to IV thrombolysis in middle cerebral artery ischemic stroke Neurology, July 15, 2008; 71(3): 190 - 195. [Abstract] [Full Text] [PDF]

				M. T. McCormick, K. W. Muir, C. S. Gray, and M. R. Walters Management of Hyperglycemia in Acute Stroke: How, When, and for Whom? Stroke, July 1, 2008; 39(7): 2177 - 2185. [Full Text] [PDF]

				E. L. Air and B. M. Kissela Diabetes, the Metabolic Syndrome, and Ischemic Stroke: Epidemiology and possible mechanisms Diabetes Care, December 1, 2007; 30(12): 3131 - 3140. [Full Text] [PDF]

				J. De Keyser, Z. Gdovinova, M. Uyttenboogaart, P. C. Vroomen, and G. J. Luijckx Intravenous Alteplase for Stroke: Beyond the Guidelines and in Particular Clinical Situations Stroke, September 1, 2007; 38(9): 2612 - 2618. [Abstract] [Full Text] [PDF]

				J. Dawson and M. Walters New and emerging treatments for stroke Br. Med. Bull., November 7, 2006; (2006) ldl011v1. [Abstract] [Full Text] [PDF]

				M. Rubiera, M. Ribo, R. Delgado-Mederos, E. Santamarina, P. Delgado, J. Montaner, J. Alvarez-Sabin, and C. A. Molina Tandem Internal Carotid Artery/Middle Cerebral Artery Occlusion: An Independent Predictor of Poor Outcome After Systemic Thrombolysis Stroke, September 1, 2006; 37(9): 2301 - 2305. [Abstract] [Full Text] [PDF]

				S. R. Martini, M. D. Hill, A. V. Alexandrov, C. A. Molina, and T. A. Kent Outcome in hyperglycemic stroke with ultrasound-augmented thrombolytic therapy. Neurology, August 22, 2006; 67(4): 700 - 702. [Abstract] [Full Text] [PDF]

				C. A. Molina Imaging the Clot: Does Clot Appearance Predict the Efficacy of Thrombolysis? Stroke, November 1, 2005; 36(11): 2333 - 2334. [Full Text] [PDF]